OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Molecular Diagnostics is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence	72
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study	65
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment	61
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination	54
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA	47
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer	36
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects	33
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features	32
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma	31
Polygenic and Network-based studies in risk identification and demystification of cancer	29
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer	29
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer	28
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis	27
Gene fusions in vascular tumors and their underlying molecular mechanisms	27
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling	26
Cost analyses for malaria molecular diagnosis for research planners in India and beyond	25
Nuclease activity: an exploitable biomarker in bacterial infections	25
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome	24
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology	24
What makes a « good » companion diagnostic in thoracic oncology?	24
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma	24
The current and future applications of in situ hybridization technologies in anatomical pathology	24
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma	23